Fortunately for Impedimed, the updated NCCN guidelines specify just 'surgery' to the lymph nodes- which is why nearly all of the newly issued policies don't place restrictions according to the type of surgery. Most of the revenue , at least for the foreseeable future , will be coming from US lymphedema , so that is important.
Media, page-42
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $153.7M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.7¢ | 7.4¢ | $140.4K | 1.863M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 149896 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 136785 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
0.000 ( 2.56 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 7.8¢ | 7.4¢ | 410811 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| IPD (ASX) Chart |